← European Medicine Shortage Tracker · all medicines

Rosuvastatin shortage — availability across Europe

Name: European Medicine Shortage Tracker dataset
Creator: MobiDoctor
License: https://creativecommons.org/licenses/by/4.0/

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Rosuvastatin currently has availability issues reported in 4 European registers: Spain, Ireland, Italy, Sweden.

Shortage ATC — · also listed as: ROSUVASTATIN CALCIUM · ROSUVASTATINA · Rosuvastatin · rosuvastatinkalcium · data refreshed 9 September 2026

Key facts

As of 9 September 2026, Rosuvastatin has active availability issues in 4 of 9 tracked European registers.
Registers reporting issues: Spain, Ireland, Italy, Sweden.
Latest expected-resolution date on file: 2029-08-01.
Longest-running open report: since 2023-12-31 (33 months, Italy).
Data source: 5 official medicines-agency registers, refreshed daily.

As of 9 September 2026, 4 of the 9 tracked registers list current availability issues for Rosuvastatin, covering 14 affected product presentations. The longest-running open report was filed in Italy on 2023-12-31 and has now been open for about 33 months. Where agencies state a cause, manufacturing problems lead with 5 of the 6 stated-cause reports, followed by unexpectedly high demand with 1. The furthest expected-resolution date currently on file is 2029-08-01; the earliest is 2026-10-01. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 5 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2023-12-31), with Spain following roughly 29 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Ireland, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇦🇹 Austria	Resolved Rosuvastatin Actavis Group 10 mg Filmtabletten	2026-06-23	—	—	register ↗
🇪🇸 Spain	Shortage ROSUVASTATINA VIATRIS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos + 3 more products ROSUVASTATINA VIATRIS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos ROSUVASTATINA VIATRIS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos ROSUVASTATINA VISO FARMACEUTICA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos	2026-05-25	2027-02-08	Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.	register ↗
🇮🇪 Ireland	Shortage Crestor 20 mg film-coated tablets + 3 more products Rosuvastatin Viatris 10 mg film-coated tablets Rosuvastatin Viatris 20 mg film-coated tablets Rosuvastatin Viatris 5 mg film-coated tablets	2026-01-09	2026-11-02	Manufacturing delay (Ireland only) Alternatives: Alternative(s) available — see the national register.	register ↗
🇮🇹 Italy	Shortage ROSUVASTATINA ADAMED + 1 more products ROSUVASTATINA SUN	2023-12-31	—	Elevata richiesta Alternatives: AIFA: equivalents with the same active substance are available.	register ↗
🇸🇪 Sweden	Shortage Crestor 40 mg Filmdragerad tablett + 3 more products Rosuvastatin Krka d.d. 20 mg Filmdragerad tablett Rosuvastatin Viatris 10 mg Filmdragerad tablett Rosuvastatin Viatris 5 mg Filmdragerad tablett	2026-05-22	2029-08-01	— Alternatives: Alternative(s) available — see the national register.	register ↗

New register reports per month

Full report history (15 register entries)

Every individual register entry for Rosuvastatin in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇪🇸 ES	ROSUVASTATINA VISO FARMACEUTICA 20 MG COMPRIMIDOS RECUBIERTOS CON PELI	Shortage	2026-08-19	—	Existen otros medicamentos con el mismo principio activo y m
🇪🇸 ES	ROSUVASTATINA VIATRIS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG,	Shortage	2026-07-29	2026-10-07	Existen otros medicamentos con el mismo principio activo y m
🇪🇸 ES	ROSUVASTATINA VIATRIS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG,	Shortage	2026-07-29	2026-12-22	Existen otros medicamentos con el mismo principio activo y m
🇮🇪 IE	Rosuvastatin Viatris 5 mg film-coated tablets	Shortage	2026-07-20	2026-11-02	Manufacturing delay (Multiple countries)
🇦🇹 AT	Rosuvastatin Actavis Group 10 mg Filmtabletten	Resolved	2026-06-23	—
🇮🇪 IE	Crestor 20 mg film-coated tablets	Shortage	2026-06-19	2026-07-30	Manufacturing delay (Ireland only)
🇸🇪 SE	Rosuvastatin Krka d.d. 20 mg Filmdragerad tablett	Shortage	2026-06-04	2026-10-01
🇸🇪 SE	Crestor 40 mg Filmdragerad tablett	Shortage	2026-06-01	2029-08-01
🇪🇸 ES	ROSUVASTATINA VIATRIS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 2	Shortage	2026-05-25	2027-02-08	Existen otros medicamentos con el mismo principio activo y m
🇸🇪 SE	Rosuvastatin Viatris 10 mg Filmdragerad tablett	Shortage	2026-05-22	2026-10-01
🇸🇪 SE	Rosuvastatin Viatris 5 mg Filmdragerad tablett	Shortage	2026-05-22	2026-10-01
🇮🇪 IE	Rosuvastatin Viatris 10 mg film-coated tablets	Shortage	2026-02-12	2026-11-02	Manufacturing delay (Multiple countries)
🇮🇪 IE	Rosuvastatin Viatris 20 mg film-coated tablets	Shortage	2026-01-09	2026-11-02	Manufacturing delay (Multiple countries)
🇮🇹 IT	ROSUVASTATINA ADAMED	Shortage	2025-10-20	—	Elevata richiesta
🇮🇹 IT	ROSUVASTATINA SUN	Shortage	2023-12-31	—	Elevata richiesta/problemi produttivi

Frequently asked

Is Rosuvastatin currently in shortage in Europe?

Yes. As of 9 September 2026, availability issues are reported in: Spain, Ireland, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Rosuvastatin shortage expected to end?

Agency prognoses on file range from 2026-10-01 to 2029-08-01. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Rosuvastatin?

14 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Rosuvastatin availability data come from?

Directly from the official medicines-agency registers that list Rosuvastatin: BASG (Austria), AEMPS CIMA (Spain), HPRA (Ireland), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Rosuvastatin — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rosuvastatin/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Rosuvastatin availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rosuvastatin/">Rosuvastatin shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Rosuvastatin: availability status across 5 European registers — European Medicine Shortage Tracker (MobiDoctor), 9 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.